P.H.B. Willemse

2.0k citations

62 papers · 1.4k indexed · h-index 22

Impact in

Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments

Papers in

Reproductive Medicine 24
- Ovarian cancer diagnosis and treatment 22
Obstetrics and Gynecology 7
- Endometrial and Cervical Cancer Treatments 7

Co-authors: Elisabeth G.E. de Vries Dirk Th. Sleijfer Nanno H. Mulder A.G.J. van der Zee E. Pras John H. Maduro J.G. Aalders D.Th. Sleijfer
Journals: International Journal of Gynecological Cancer (7 papers)Journal of Clinical Oncology (6 papers)European Journal of Cancer (5 papers)Gynecologic Oncology (4 papers)Cancer Treatment Reviews (3 papers)
Partner nations: Netherlands United States Poland

In The Last Decade

P.H.B. Willemse

62 papers receiving 1.4k citations

Peers

Countries citing papers authored by P.H.B. Willemse

Since Specialization

Citations

This map shows the geographic impact of P.H.B. Willemse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.H.B. Willemse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.H.B. Willemse more than expected).

Fields of papers citing papers by P.H.B. Willemse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.H.B. Willemse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.H.B. Willemse. The network helps show where P.H.B. Willemse may publish in the future.

Co-authors

The 25 scholars most cited alongside P.H.B. Willemse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P.H.B. Willemse Line = papers co-authored together P.H.B. Willemse links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study Annals of Oncology ·A.K.L. Reyners, Linda de Munck, Frans Erdkamp, Willem M. Smit, K. Hoekman, Roy Lalisang, H. de Graaf, A.N.M. Wymenga, M. Polée, Harry Hollema, Marcel A.T.M. van Vugt, Michael Schaapveld, P.H.B. Willemse	2012	34
2	Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer European Journal of Cancer ·M.J.A. Engelen, Bart Jorrit Snel, Michael Schaapveld, E. Pras, Elisabeth G.E. de Vries, Jourik A. Gietema, A.G.J. van der Zee, P.H.B. Willemse	2009	14
3	Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy International Journal of Gynecological Cancer ·Anne P. G. Crijns, Evelien W. Duiker, Steven de Jong, P.H.B. Willemse, A.G.J. van der Zee, Elisabeth G.E. de Vries	2006	38
4	Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy British Journal of Cancer ·Michael Schaapveld, Elisabeth G.E. de Vries, R. Otter, J. de Vries, Wil V. Dolsma, P.H.B. Willemse	2005	25
5	Neuropsychological investigation into the carcinoid syndrome Psychopharmacology ·Sara Russo, M. M. A. Nielen, J. C. Boon, Ido P. Kema, P.H.B. Willemse, Elisabeth G.E. de Vries, Jakob Korf, Johan A. den Boer	2003	33
6	The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium Journal of Clinical Pathology ·Marian J.E. Mourits, Klaske A. ten Hoor, A.G.J. van der Zee, P.H.B. Willemse, Elisabeth G.E. de Vries, Harry Hollema	2002	39
7	B.A. Chabner, D.L. Longo (eds.) Cancer Chemotherapy and Biotherapy: Principles and Practice Annals of Oncology ·Elisabeth G.E. de Vries, P.H.B. Willemse	2002	4
8	Diagnostic, surgical and medical aspect of the midgut carcinoids Cancer Treatment Reviews ·Harry de Vries, R.C.J. Verschueren, P.H.B. Willemse, Ido P. Kema, Elisabeth G.E. de Vries	2002	34
9	Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium Human Pathology ·Marian J.E. Mourits, H. Hollema, Elisabeth G.E. de Vries, K.A. Ten Hoor, P.H.B. Willemse, A.G.J. van der Zee	2002	20
10	Kinetic Modeling and Efficacy of Intraperitoneal Paclitaxel Combined with Intravenous Cyclophosphamide and Carboplatin as First-Line Treatment in Ovarian Cancer Gynecologic Oncology ·L.S. Hofstra, A.M.E. Bos, Elisabeth G.E. de Vries, A.G.J. van der Zee, Antoon T. M. Willemsen, Hilde Rosing, J. H. Beijnen, Nanno H. Mulder, J.G. Aalders, P.H.B. Willemse	2002	18
11	Delta‐5‐androstenediol and its sulphate in serum and urine of normal adults and patients with endocrine diseases Clinical Endocrinology ·L.D. Dikkeschei, P.H.B. Willemse, B.G. Wolthers, A. W. de Ruyter‐Buitenhuis, G.T. Nagel	1993	13
12	The determination of delta‐5‐androstenediol and its sulphate in serum and urine by gas chromatography‐mass spectrometry Clinical Endocrinology ·L.D. Dikkeschei, B.G. Wolthers, P.H.B. Willemse, Hemant Pol, A. W. der Ruyter‐Buitenhuis, G.T. Nagel	1993	5
13	Carboplatin with cyclophosphamide in patients with advanced ovarian cancer: an efficacy and quality-adjusted survival analysis International Journal of Gynecological Cancer ·P.H.B. Willemse, Elisabeth G.E. de Vries, M. Kloppenburg, D.L. Fontein, J.G. Aalders, H. Boonstra	1992	6
14	Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis. Journal of Clinical Oncology ·Dirk Th. Sleijfer, René A. J. Janssen, Jan Buter, Elisabeth G.E. de Vries, P.H.B. Willemse, Nanno H. Mulder	1992	140
15	CA-125 in ovarian cancer: Relation between half-life, doubling time and survival European Journal of Cancer and Clinical Oncology ·P.H.B. Willemse, Jan G. Aalders, Henk W.A. de Bruyn, Nanno H. Mulder, Dirk Th. Sleijfer, Elisabeth G.E. de Vries	1991	20
16	Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results Cancer Chemotherapy and Pharmacology ·P.H.B. Willemse, M.E.L.v.d. Burg, Ate van der Gaast, J.P. Neijt, W.W. ten Bokkel Huinink, J.G. Aalders, Elisabeth G.E. de Vries	1990	12
17	Bleeding Prophylaxis in Autologous Bone Marrow Transplantation for Solid Tumors Pathophysiology of Haemostasis and Thrombosis ·P. O. M. Mulder, Annelies Maas, Elisabeth G.E. de Vries, J.L.M. Orie, Dirk Th. Sleijfer, Cees Th. Smit Sibinga, P.H.B. Willemse, N. H. Mulder	1989	5
18	Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma Journal of Cancer Research and Clinical Oncology ·N. H. Mulder, Dirk Th. Sleijfer, Elisabeth G.E. de Vries, H. Schraffordt Koops, Michael Samson, P.H.B. Willemse	1989	9
19	Evaluation of a totally implanted venous access port and portable pump in a continuous chemotherapy infusion schedule on an outpatient basis European Journal of Cancer and Clinical Oncology ·J. W. Greidanus, Elisabeth G.E. de Vries, M.B. Nieweg, Zacharias J. de Langen, P.H.B. Willemse	1987	11
20	Scintigraphy with 201Tl for detection of thyroid cancer metastases European Journal of Nuclear Medicine and Molecular Imaging ·D.A. Piers, Wim J. Sluiter, P.H.B. Willemse, H Doorenbos	1982	11

About P.H.B. Willemse

P.H.B. Willemse is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Dermatology and Pathology and Forensic Medicine, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (22 papers), Testicular diseases and treatments (10 papers), Intraperitoneal and Appendiceal Malignancies (10 papers), Neutropenia and Cancer Infections (9 papers), Endometrial and Cervical Cancer Treatments (7 papers), Estrogen and related hormone effects (7 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Reproductive Medicine (467 citations), Obstetrics and Gynecology (201 citations), Oncology (486 citations), Surgery (391 citations) and Toxicology (26 citations). P.H.B. Willemse has collaborated with scholars based in Netherlands, United States and Poland. Frequent co-authors include Elisabeth G.E. de Vries, Dirk Th. Sleijfer, Nanno H. Mulder, A.G.J. van der Zee, E. Pras, John H. Maduro, J.G. Aalders, D.Th. Sleijfer, René A. J. Janssen and H Doorenbos. Their work appears in journals such as International Journal of Gynecological Cancer, Journal of Clinical Oncology, European Journal of Cancer, Gynecologic Oncology and Cancer Treatment Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact